Strategies to Improve the Impact of Artificial Intelligence Applications on Health Equity: Scoping Review
ABSTRACT
Background:
Artificial intelligence (AI) is increasingly used in health applications despite concerns about biased decision-making and health equity. For example, algorithms may perpetuate biases and discriminatory behaviors encoded in health data.
Objective:
In this study, we aimed to provide a comprehensive view of the health equity issues related to the use of AI and the strategies proposed to address them.
Methods:
We reviewed academic and grey literature sources to identify 18 issues and 15 strategies and document a many-to-many mapping of which strategies are proposed to address each issue.
Results:
Equity issues arising from data characteristics and model design dominate the literature, many of which are best addressed by multiple complementary strategies. The optimal set of strategies depends on the issues facing the application, which stakeholders are engaged, and the resources available.
Conclusions:
Many AI health equity efforts will use some of the four most commonly proposed strategies: improving the quantity and quality of data, evaluating the disparities introduced by an application, involving the broader community in AI development, and improving governance. In addition, some low-overhead strategies can be considered for every application, such as considering whether the use of AI should be reduced or adopting equity-focused checklists. This scoping review aids stakeholders in creating sets of strategies that both address a broad range of equity concerns and focus on the most significant issues in their application.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.